Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription The portion meant for qualified institutional buyers (QIBs) was subscribed 50 per cent, while the non-institutional investors' category received 1.14 times subscription and those for retail individual investors (RIIs) 8.24 times, according to an update on NSE. https://ift.tt/eA8V8J
No comments:
Post a Comment